A new FDA study that compared blood thinner drugs
Pradaxa and warfarin shows that individuals who use Pradaxa are at higher risk of suffering from major gastrointestinal (GI) bleeding than those who use warfarin. On the flip side, warfarin users are shown to be at higher risk of suffering from strokes related to blood clots, bleeding in the brain and death. For the side effect of myocardial infraction (MI), or heart attack, the risk level is shown to be about the same for the two drugs.
Pradaxa and warfarin are anticoagulants taken by patients with atrial fibrillation (a heart rhythm disorder) for the purpose of reducing the risk of stroke and blood clots.
The information of more than 134,000 Medicare patients was used for this FDA study. The study subjects were 65 years of age or older. The FDA conducted multiple reviews of Pradaxa after it received a high volume of reports that this blood thinner was causing bleeding in those who took the drug. According to the FDA, the most recent study differed from its previous review in that it used more advanced methodology, as well as a larger and older study population.
While the FDA has chosen not to order that any changes be made to the drug, its labeling or its instructions for use, the public should still be aware of the harmful effects this drug is capable of causing. There have been many individuals who have suffered serious health complications or have even died as a result of taking Pradaxa.
Our law firm, Jackson Allen & Williams, LLP is ready to advocate for victims and their loved ones who have been harmed by this drug. Our dangerous drug attorneys are currently accepting Pradaxa cases, so do not hesitate to call us if you believe that you are a victim.
Contact Jackson Allen & Williams for help obtaining the compensation you deserve!